Clinical and serologic factors associated with lupus pleuritis

Journal of Rheumatology

Volumn 37, Issue 4, 2010, Pages 747-753

  Mittoo, Shikha ^a   Gelber, Allan C ^b   Hitchon, Carol A ^a   Silverman, Earl D ^c   Pope, Janet E ^d   Fortin, Paul R ^e   Pineau, Christian ^f   Smith, C Douglas ^g   Arbillaga, Hector ^h   Gladman, Dafna D ^e   Urowitz, Murray B ^e   Zummer, Michel ⁱ   Clarke, Ann E ^f   Bernatsky, Sasha ^f   Hudson, Marie ^f   Tucker, Lori B ^j   Petty, Ross E ^j   Cooper, Glinda S ^k   Albert, Lori ^e   Chedéville, Gaëlle ^l   Campillo, Sarah ^l   Duffy, Karen ^l   Scuccimarri, Rosie ^l   Baron, Murray ^m   Berkson, Laeora ^m   Ramsey, Suzanne ⁿ   Huber, Adam ⁿ   Peschken, Christine A ^a   more..

^a UNIVERSITY OF MANITOBA   (Canada)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f MCGILL UNIVERSITY   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

^h Chinook Regional Hospital   (Canada)

ⁱ UNIVERSITÉ DE MONTRÉAL   (Canada)

^j UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^k U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^l MONTREAL CHILDREN S HOSPITAL   (Canada)

^m MCGILL UNIVERSITY   (Canada)

ⁿ DALHOUSIE UNIVERSITY   (Canada)

more..

Author keywords

Antibodies; Pulmonary disease; Systemic lupus erythematosus

Indexed keywords

CELL NUCLEUS ANTIGEN; RIBONUCLEOPROTEIN;

ADULT; ARTICLE; CAUCASIAN; CLINICAL EVALUATION; CLINICAL TRIAL; COHORT ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SATISFACTION; PLEURISY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGE FACTORS; AGE OF ONSET; AUTOANTIBODIES; CANADA; COHORT STUDIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLEURISY; PREVALENCE; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 77950688279     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090249     Document Type: Article

References (40)

1. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-1277 (Pubitemid 13221242)
2. Turner-Stokes L, Turner-Warwick M. Intrathoracic manifestations of SLE. Clin Rheum Dis 1982;8:229-242
3. Purice S, Tudor A, Gheorghiu M, Matei I, Balta M, Cojocaru M, et al. Pulmonary involvement in systemic lupus erythematosus. Med Interne 1987;25:227-232
4. Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992;10:527-539
5. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1993;72:113-124
6. Cook RJ, Gladman DD, Pericak D, Urowitz MB. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J Rheumatol 2000;27:1892-1895 (Pubitemid 30670482)
7. Putterman C. New approaches to the renal pathogenicity of anti-DNA antibodies in systemic lupus erythematosus. Autoimmun Rev 2004;3:7-11. (Pubitemid 38293360)
8. Lefkowith JB, Gilkeson GS. Nephritogenic autoantibodies in lupus: current concepts and continuing controversies. Arthritis Rheum 1996;39:894-903.
9. Migliorini P, Baldini C, Rocchi V, Bombardieri S. Anti-Sm and anti-RNP antibodies. Autoimmunity 2005;38:47-54.
10. Groen H, ter Borg EJ, Postma DS, Wouda AA, van der Mark TW, Kallenberg CG. Pulmonary function in systemic lupus erythematosus is related to distinct clinical, serologic, and nailfold capillary patterns. Am J Med 1992;93:619-627
11. Nguyen VA, Gotwald T, Prior C, Oberrnoser G, Sepp N. Acute pulmonary edema, capillaritis and alveolar hemorrhage: pulmonary manifestations coexistent in antiphospholipid syndrome and systemic lupus erythematosus? Lupus 2005;14:557-560
12. Boulware DW, Hedgpeth MT. Lupus pneumonitis and anti-SSA(Ro) antibodies. J Rheumatol 1989;16:479-481
13. Galeazzi M, Morozzi G, Sebastiani GD, Bellisai F, Marcolongo R, Cervera R, et al. Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLE. Clin Exp Rheumatol 1998;16:541-546 (Pubitemid 28439435)
14. Silberstein SL, Barland P, Grayzel AI, Koerner SK. Pulmonary dysfunction in systemic lupus erythematosus: prevalence classification and correlation with other organ involvement. J Rheumatol 1980;7:187-195 (Pubitemid 11222932)
15. Ishii M, Uda H, Yamagami T, Katada Y. Possible association of "shrinking lung" and anti-Ro/SSA antibody. Arthritis Rheum 2000;43:2612-2613
16. Bertoli AM, Vila L, Apte M, Fessler BJ, Bastian HM, Reveille JD, et al. Systemic lupus erythematosus in a multiethnic US cohort. LUMINA XLVIII: factors predictive of pulmonary damage. Lupus 2007;16:410-417
17. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-640
18. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-1118
19. Uribe AG, Vila LM, McGwin G Jr, Sanchez ML, Reveille JD, Alarcon GS. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol 2004;31:1934-1940.
20. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-369 (Pubitemid 26085211)
21. Statistics Canada. Classification for race. Ottawa: Statistics Canada; 2008. [Internet. Accessed Dec 18, 2009.] Available from: http://www.statcan.gc. ca/concepts/definitions/ethnicity01-ethnicite01-eng.htm
22. Pines A, Kaplinsky N, Olchovsky D, Rozenman J, Frankl O. Pleuro-pulmonary manifestations of systemic lupus erythematosus: clinical features of its subgroups. Prognostic and therapeutic implications. Chest 1985;88:129-135
23. Man BL, Mok CC. Serositis related to systemic lupus erythematosus: prevalence and outcome. Lupus 2005;14:822-826 (Pubitemid 41597617)
24. Gomez J, Suarez A, Lopez P, Mozo L, Diaz JB, Gutierrez C. Systemic lupus erythematosus in Asturias, Spain: clinical and serologic features. Medicine (Baltimore) 2006;85:157-168
25. Cervera R, Abarca-Costalago M, Abramovicz D, Allegri F, Annunziata P, Aydintug AO, et al. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project" Autoimmun Rev 2006;5:180-186
26. Boddaert J, Huong DL, Amoura Z, Wechsler B, Godeau P, Piette JC. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine (Baltimore) 2004;83:348-359 (Pubitemid 39541112)
27. Jindal SK, Agarwal R. Autoimmunity and interstitial lung disease. Curr Opin Pulm Med 2005;11:438-446
28. Turner-Warwick M, Doniach D. Auto-antibody studies in interstitial pulmonary fibrosis. Br Med J 1965;1:886-891
29. Chapman JR, Charles PJ, Venables PJ, Thompson PJ, Haslam PL, Maini RN, et al. Definition and clinical relevance of antibodies to nuclear ribonucleoprotein and other nuclear antigens in patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis 1984;130:439-443
30. Swaak AJ, Huysen V, Nossent JC, Smeenk RJ. Antinuclear antibody profiles in relation to specific disease manifestations of systemic lupus erythematosus. Clin Rheumatol 1990;9 Suppl:82-94.
31. Hitchon CA, Peschken CA. Sm antibodies increase risk of death in systemic lupus erythematosus. Lupus 2007;16:186-194 (Pubitemid 46506596)
32. Winn DM, Wolfe JF, Lindberg DA, Fristoe FH, Kingsland L, Sharp GC. Identification of a clinical subset of systemic lupus erythematosus by antibodies to the SM antigen. Arthritis Rheum 1979;22:1334-1337 (Pubitemid 10194571)
33. Yasuma M, Takasaki Y, Matsumoto K, Kodama A, Hashimoto H, Hirose S. Clinical significance of IgG anti-Sm antibodies in patients with systemic lupus erythematosus. J Rheumatol 1990;17:469-475 (Pubitemid 20152196)
34. Jurencak R, Fritzler M, Tyrrell P, Hiraki L, Benseler S, Silverman E. Autoantibodies in pediatric systemic lupus erythematosus: ethnic grouping, cluster analysis, and clinical correlations. J Rheumatol 2009;36:416-421
35. Keith MP, Moratz C, Tsokos GC. Anti-RNP immunity: implications for tissue injury and the pathogenesis of connective tissue disease. Autoimmun Rev 2007;6:232-236 (Pubitemid 46274548)
36. Greidinger EL, Zang Y, Jaimes K, Hogenmiller S, Nassiri M, Bejarano P, et al. A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen. Arthritis Rheum 2006;54:661-669 (Pubitemid 43228645)
37. Keith MP, Moratz C, Egan R, Zacharia A, Greidinger EL, Hoffman RW, et al. Anti-ribonucleoprotein antibodies mediate enhanced lung injury following mesenteric ischemia/reperfusion in Rag-1(-/-) mice. Autoimmunity 2007;40:208-216 (Pubitemid 46680974)
38. Greidinger EL, YunJuan Z, Fernandez I, Mariana B, Mehdi N, Martinez L, et al. Tissue targeting of anti-RNP autoimmunity: Effects of T cells and myeloid dendritic cells in a murine model. Arthritis Rheum 2009;60:534-542
39. Gladman DD, Urowitz MB, Rahman P, Ibanez D, Tam LS. Accrual of organ damage over time in patients with systemic lupus erythematosus. J Rheumatol 2003;30:1955-1959 (Pubitemid 37075543)
40. Jimenez S, Cervera R, Font J, Ingelmo M. The epidemiology of systemic lupus erythematosus. Clin Rev Allergy Immunol 2003;25:3-12.